When to Biopsy a Wound: Referral Criteria for Clinicians

When to Biopsy a Wound: Recognizing Referral Triggers

Not every non-healing wound needs a biopsy. But every wound care clinician needs to know when one does. A wound biopsy referral that arrives three months too late -- after the wound has expanded, the tissue has changed, and the patient has endured weeks of ineffective treatment -- represents a systems failure that starts with the clinician at the bedside.

Knowing when to biopsy a wound is about pattern recognition. The patterns described here should trigger biopsy consideration in any wound care practice.

The Four-Week Rule and Its Limits

The most commonly cited biopsy trigger in wound care is the four-week rule: if a wound has not reduced in area by at least 40-50% after four weeks of appropriate standard care, the diagnosis should be reconsidered and biopsy may be indicated.

This rule is useful as a general checkpoint but has significant limitations:

It assumes the initial diagnosis was correct and that standard care was truly appropriate for that diagnosis
It does not account for wounds that are progressing slowly but steadily -- a wound reducing by 30% at four weeks may be on trajectory and not require biopsy
It does not flag wounds that SHOULD be biopsied earlier because their presentation is atypical from day one

The four-week rule is a safety net, not a diagnostic tool. The clinical features described below should trigger biopsy consideration regardless of wound age.

Atypical Wound Features That Warrant Biopsy

Wound Edge Characteristics

The wound edge tells you more about the underlying pathology than the wound bed in many atypical wounds.

Biopsy triggers:

Rolled, heaped, or everted wound edges -- classic presentation of squamous cell carcinoma arising in a chronic wound (Marjolin's ulcer). The edges appear thickened, raised, and irregular compared to normal wound margins.
Undermined or violaceous (purple) wound edges -- suggestive of pyoderma gangrenosum, vasculitis, or other inflammatory dermatoses. These wounds expand rapidly and are worsened by debridement (pathergy).
Irregular, asymmetric wound borders that do not follow expected wound healing patterns. Uniform expansion or irregular geographic patterns suggest a systemic or neoplastic process rather than a local wound healing failure.

Wound Bed Characteristics

Exuberant, friable tissue that bleeds easily and does not respond to standard granulation-promoting therapy -- consider squamous cell carcinoma, basal cell carcinoma, or sarcoma
Necrotic tissue that reforms rapidly after debridement without infection -- consider vasculitis, calciphylaxis, or ischemic etiology not addressed by current treatment
Unusual wound bed color -- blue-gray discoloration may indicate melanoma; yellow-white nodular tissue may suggest xanthoma or foreign body granuloma

Pain Pattern

Pain disproportionate to wound appearance, especially in lower extremity ulcers, should raise suspicion for vasculitis, pyoderma gangrenosum, or arterial insufficiency not captured by ABI testing
Pain in a previously painless chronic wound that suddenly changes character warrants reassessment and potential biopsy

Marjolin's Ulcer: The Wound Care Clinician's Responsibility

Marjolin's ulcer is squamous cell carcinoma arising in a chronic wound, scar, or area of chronic inflammation. It is the single most important reason wound care clinicians must maintain biopsy vigilance.

Risk Profile

Chronic wounds present for >3 months, with highest risk in wounds lasting years
Burn scars, especially those from childhood burns
Chronic venous ulcers
Chronic pressure injuries
Chronic osteomyelitis sinuses
Areas of chronic radiation dermatitis

Clinical Features

Change in wound character after a long period of stability or slow healing
Development of raised, nodular, or cauliflower-like tissue at the wound edge or bed
Increased pain in a previously stable wound
Foul-smelling, friable tissue that bleeds with minimal manipulation
Rapid expansion of a previously stable wound

Key Point

Marjolin's ulcers are aggressive. They metastasize at higher rates than primary cutaneous squamous cell carcinoma because diagnosis is frequently delayed -- the malignancy hides inside a wound that the clinical team has normalized as "chronic." Biopsy is the only way to diagnose it. A high index of suspicion in any wound present for more than three months is the standard of care.

Biopsy Technique Overview

Wound biopsies in the outpatient wound care setting are typically performed as punch biopsies. The wound care clinician may perform the biopsy directly (within scope of practice) or refer to dermatology or surgery.

Punch Biopsy Technique

Select the biopsy site at the wound edge, capturing both wound bed tissue AND adjacent intact skin. A biopsy taken only from the wound center may miss the diagnostic tissue at the margin.
Use a 4mm or 6mm punch biopsy tool
Local anesthesia: inject 1% lidocaine with epinephrine (unless contraindicated by location) at the biopsy site
Rotate the punch tool through the full skin thickness
Lift the specimen with forceps or a needle -- do not crush the tissue with forceps
Place in 10% formalin for histopathology
Achieve hemostasis at the biopsy site with pressure, silver nitrate, or a single suture if needed

How Many Biopsies

For wounds suspicious for malignancy, a minimum of two biopsies from different areas of the wound edge is recommended. A single negative biopsy does not rule out malignancy -- sampling error is the primary cause of false-negative wound biopsies.

For inflammatory dermatoses (suspected pyoderma gangrenosum, vasculitis), one biopsy from the active wound edge is typically sufficient for diagnosis, but additional specimens for direct immunofluorescence (DIF) may be needed. Communicate with the pathologist before the biopsy about what diagnoses you are considering.

Pathology Coordination

The biopsy is only as useful as the pathology request that accompanies it.

Include on the pathology requisition:

Clinical history: wound duration, location, prior treatments, rate of change
Differential diagnosis: list what you are considering (SCC, BCC, pyoderma gangrenosum, vasculitis, calciphylaxis)
Special stains requested: specify if you need PAS (fungal), AFB (mycobacterial), DIF (autoimmune), or tissue culture (atypical infection)
Relevant clinical context: immunosuppression status, radiation history, prior malignancy

A pathology report that reads "chronic ulceration with granulation tissue" on a wound you biopsied because you suspected malignancy means the pathologist did not know what you were looking for. Communication prevents this.

Key Takeaways

The four-week rule is a safety net, not a diagnostic threshold -- atypical wound features should trigger biopsy consideration from the first visit regardless of wound age
Rolled, heaped, or everted wound edges are the hallmark of Marjolin's ulcer (squamous cell carcinoma in chronic wounds) and require immediate biopsy
Biopsy the wound edge, not the center -- capture the margin between wound bed and intact skin for the most diagnostic specimen
Take at least two biopsies from different wound edge locations when malignancy is suspected to reduce false-negative sampling error
Include your differential diagnosis and special stain requests on the pathology requisition -- the pathologist needs to know what you are considering